niacinamide has been researched along with inosine diphosphate in 159 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (2.52) | 29.6817 |
| 2010's | 140 (88.05) | 24.3611 |
| 2020's | 15 (9.43) | 2.80 |
| Authors | Studies |
|---|---|
| Alekseeva, LE; Bul'on, VV; Evdokimova, NR; Kovalenko, AL; Krylova, IB; Sapronov, NS | 1 |
| Alekseeva, LE; Bul'on, VV; Kovalenko, AL; Kuznetsova, NN; Sapronov, NS; Selina, EN | 1 |
| Khazanov, VA; Vasilyev, KY | 1 |
| Bagnenko, SF; Chupris, VG; Kurygin, AA; Sinenchenko, GI | 1 |
| Kosinets, VA | 3 |
| Aksenov, VV; Glushkov, SI; Kashuro, VA; Novikova, TM | 1 |
| Beĭn, BN; Dravert, NE | 1 |
| Pugacheva, EL; Skoromets, AA | 1 |
| Fatullaeva, KF; Nurov, AU; Saltanov, AI | 1 |
| Bragina, SV; Ovezov, AM; Prokoshev, PV | 1 |
| Balunov, OA; Dubinina, EE; Trofimova, SA | 1 |
| Isakov, VA; Kovalenko, AL; Makarov, VI; Turkin, VV | 1 |
| Amagyrov, VP; Batotsyrenov, BV; Batotsyrenova, KhV; Livanov, GA; Lodiagin, AN | 1 |
| Klocheva, EG; Kovalenko, AL; Piradov, MA; Romantsov, MG; Rumiantseva, SA; Suslina, ZA | 1 |
| Iunusov, IA; Shabanov, PD; Zarubina, IV | 1 |
| Siluianov, SV; Smirnov, GO; Sobirov, MA; Stupin, VA | 1 |
| Bolevich, SB; Fedin, AI; Goluzova, IuN; Iliukhina, OA; Men'shova, NI; Rumiantseva, SA; Silina, EV; Vasil'ev, IuD | 1 |
| Bagnenko, SF; Klocheva, EG; Kovalenko, AL; Piradov, MA; Romantsov, MG; Rumintseva, SA; Semke, VIa; Sukhanov, DS; Suslina, ZA | 1 |
| Zhuravskiĭ, SG | 1 |
| Aleksandrov, MV; Andrianov, AIu; Batotsyrenov, BV; Kuznetsov, OA; Loladze, AT; Shikalova, IA; Vasil'ev, SA | 1 |
| Glushkov, SI; Kashuro, VA; Zheregelia, SN | 1 |
| Pochepen', ON | 1 |
| Marysheva, VV; Shabanov, PD; Yunusov, IA; Zarubina, IV | 1 |
| Avakian, AA; Degtiareva, EA; Mikheeva, AA; Romantsov, MG; Zhdanova, OI | 1 |
| Glushkov, SI; Karpishchenko, SN; Zheregelia, SN | 1 |
| Golokhvastov, SIu; Ianishevskiĭ, SN; Klocheva, EG; Novikova, LB; Odinak, MM; Rumiantseva, SA; Skvortsova, VI; Stakhovskaia, LV; Tsygan, NV; Vozniuk, IA | 1 |
| Degtiareva, MG; Grebennikova, OV; Marganiia, MSh; Rogatkin, SO; Serova, ND; Volodin, NN | 1 |
| Bisaga, GN; Boĭko, AN; Mel'nik, IuB; Odinak, MM; Popova, NF | 1 |
| Bolevich, SB; Omarov, IA; Savateeva-Liubimova, TN; Silina, EV; Sivak, KV | 1 |
| Glushkov, SI; Kashuro, VA; Minaeva, LV; Novikova, TM | 1 |
| Fedin, AI; Klocheva, EG; Kovalenko, AL; Rumiantseva, SA; Sholomov, II; Silina, EV; Skoromets, AA; Suslina, ZA; Tanashian, MM | 1 |
| Antipenko, EA; Gustov, AV | 1 |
| Bogomolov, MS; Edovina, LN; Luk'ianov, IuV; Sedov, VM; Slobodianiuk, VV | 1 |
| Domitrak, SV; Lavrik, SIu; Shprakh, VV | 1 |
| Kichigina, EV; Kosenkova, NV; Larikova, TN; Shestakov, VV; Starikova, NL | 1 |
| Anashchenko, AV; Evdokimov, AV; Liapina, EP; Reshetnikov, AA; Shul'diakov, AA; Soboleva, LA; Trubetskov, AD; Zubareva, EV | 1 |
| Bakhareva, IuA; Nadiradze, ZZ | 1 |
| Asmolova, GA; Degtiareva, MG; Grebennikova, OV; Rogatkina, SO; Serova, ND; Sigova, IuA; Volodin, NN | 1 |
| Gordiushina, IV; Petrov, AIu; Romantsov, MG; Savchenko, RP; Sukhanov, DS | 1 |
| Ivanova, LG; Tumanian, SV | 1 |
| Denisenko, AN; Gordeeva, OS; Iakovlev, AIu; Ulitin, DN; Vorontsov, AIu | 1 |
| Chesnokova, NP; Ostrovskiĭ, NV; Polutova, NV; Romantsov, MG | 1 |
| Maskin, SS; Mochaĭlo, IuA; Pchelintsev, KE; Ponomarev, EA; Strepetov, NN | 1 |
| Baĭtursunova, ZhM; Madzhidova, EN; Usmanova, DD | 2 |
| Chernookiĭ, OG; Kardash, OF; Krachak, DI; Ostrovskiĭ, IuP; Shestakova, LG; Zasetskiĭ, AE | 1 |
| Egorova, ES; Skripchenko, NV | 1 |
| Kliuĭko, DA; Korik, VE; Zhidkov, SA | 1 |
| Maskin, SS; Petrov, VI; Ponomarev, ÉA; Strepetov, NN | 1 |
| Bagnenko, SF; Batotsyrenov, BV; Batotsyrenova, KhV; Gorbachev, NB; Miroshnichenko, VN; Mirzabaev, AT; Velikiĭ, KF | 1 |
| Afanas'ev, VV; Petrova, AG; Provado, IP; Zobnin, IuV | 1 |
| Batotsyrenov, BV; Loladze, AT; Shikalova, IA; Shilov, VV; Vasil'ev, SA | 1 |
| Golub, IE; Ivankova, EN; Kovalenko, AL; Pinskiĭ, SB; Sorokina, LV | 1 |
| Batotsyrenov, B; Kuznetsov, O; Loladze, A; Shilov, V; Vasilyev, S | 1 |
| Aleksandrov, M; Batotsyrenov, B; Loladze, A; Shilov, V; Vasilyev, S | 1 |
| Adamenko, GP; Gostishchev, VK; Kosinets, VA; Matusevich, EA | 1 |
| Dikova, OV; Laseev, DI | 1 |
| Andrianov, AIu; Batotsyrenova, KhV; Loladze, AT; Shilov, VV; Vasil'ev, SA | 1 |
| Kon'kova-Reĭdman, AB; Ratnikova, LI | 1 |
| Iarotskaia, NN; Kosinets, VA; Osochuk, SS | 1 |
| Aleksandrov, MV; Batotsyrenov, BV; Kuznetsov, OA; Shilov, VV; Vasil'ev, SA | 1 |
| Bolevich, SB; Men'shova, NI; Rumiantseva, SA; Silina, EV | 1 |
| Matusevich, EA | 1 |
| Gonchar, IV; Kuranova, ML; Rozanov, IuM; Tiuriaeva, II | 1 |
| Batotsyrenov, BV; Kuznetsov, OA; Loladze, AT; Shilov, VV; Vasil'ev, SA | 1 |
| Petrova, AG; Selezneva, AG | 1 |
| Kosinets, VA; Shturich, IP; Stolbitskiĭ, VV | 1 |
| Abramova, VV; Belova, LA; Belova, NV; Byrina, AV; Evstigneeva, AIu; Kolotik-Kameneva, OIu; Mashin, VV | 1 |
| Batotsyrenova, KhV; Livanov, GA; Shestova, GV; Sizova, KV; Velikova, VD | 1 |
| Bolevich, SB; Manturova, NE; Silina, EV; Smirnova, GO; Stupin, VA | 1 |
| Iarotskaia, NN; Kosinets, VA | 1 |
| Asadullaev, MM; Rizvonov, ZhK; Saidvaliev, FS; Shermukhamedova, FK; Vakhabova, NM | 1 |
| Erkebaeva, SK; Gafurov, BG; Nurguzhaev, ES; Tuksanbaeva, GU | 1 |
| Andriaov, AY; Batotsyrenov, BV; Loladze, AT; Shilov, VV | 1 |
| Antipenko, EA; Deriugina, AV; Krylov, VN; Zakharova, OA | 1 |
| Drozd, OA; Dudarev, IV; Efremov, VV | 1 |
| Aleksandrova, LN; Kovalenko, AL; Petrov, AIu; Romantsov, MG; Sukhanov, DS | 1 |
| Ermakova, SG; Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Lagvilava, TO; Nesterov, IuV; Zinov'ev, EV | 1 |
| Artemchuk, KA; Goloshchapov, VV; Kuz'minov, VN; Linskiĭ, IV; Minko, AI; Samoĭlova, ES | 1 |
| Belov, VG; Okovityĭ, SV; Parfenov, IuA | 1 |
| Beletskiĭ, AV; Nikonov, VV; Pavlenko, AIu | 1 |
| Khaĭdarova, DK; Khodzhaeva, DT; Madzhidova, EN | 1 |
| Belova, AE; Chudakova, TK; Danilova, AN; Dubovitskaia, NA; Mikhaĭlova, EV; Romanovskaia, AV | 1 |
| Parfenov, SA; Volodina, KI; Vorob'eva, NV | 1 |
| Gekht, AB; Gudkova, AN; Osinovskaia, NA; Polunina, AG | 2 |
| Andrianov, AIu; Batotsyrenov, BV; Livanov, GA; Lodiagin, AN; Nikolaeva, IP | 1 |
| Tsygan, IV | 1 |
| Batotsyrenov, BV; Kuznetsov, OA; Loladze, AT; Nezhentseva, IV; Vasil'ev, SA | 1 |
| Belov, VG; Khaĭrutdinov, DR; Parfenov, IuA; Zaplutanov, VA | 2 |
| Belov, VG; Parfenov, IuA; Zaplutanov, VA | 1 |
| Gorbach, TV; Romashchenko, OV; Rumbesht, VV; Zhernakova, NI | 1 |
| Belousova, ME; Kaminskiĭ, MIu; Kurtasov, AA; Lebedeva, EA; Nemkova, ZA; Popov, RV; Trofimovich, SL | 2 |
| Kartashova, EA; Romantsov, MG; Sarvilina, IV | 2 |
| Antropova, NV; Kustikova, IN; Moiseeva, IIa; Rodina, OP; Vodop'ianova, OA | 3 |
| Belova, LA; Kolotik-Kameneva, OIu; Mashin, EV; Mashin, VV; Saprygina, LV | 1 |
| Kovalenko, AL; Mikhaloĭko, IIa; Sabadosh, RV; Skripko, VD | 1 |
| Chichanovskaya, LV; Kabaeva, EN; Kovalenko, AL; Nazarov, MV; Rumyantseva, SA; Silina, EV; Stupin, VA; Tsukurova, LA | 1 |
| Galkin, AS; Khafizova, TL; Kovalchuck, VV | 1 |
| Chichanovskaia, LV; Eliseev, EV; Kabaeva, EN; Kovalenko, AL; Lukin, DI; Nazarov, MV; Nedorostkova, TIu; Rumiantseva, SA; Silina, EV; Stupin, VA; Tsukurova, LA | 1 |
| Chuev, IuF; D'iachenko, TV; Goncharova, EIu; Kasparevich, AIu; Kovalenko, AL; Krivosheeva, MD; Skalyga, IM; Sosin, IK | 1 |
| Anisimov, VN; Bazhanova, ED; Sukhanov, DS; Teplyĭ, DL | 1 |
| Chichanovskaia, LV; Kabaeva, EN; Kovalenko, AL; Nazarov, MV; Rumiantseva, SA; Silina, EV; Stupin, VA; Tsukurova, LA | 1 |
| Belova, LA; Kolotik-Kameneva, OY; Mashin, VV; Proshin, AN | 1 |
| Likhacheva, EB; Salina, EA; Schukovsky, NV; Sholomov, II; Stetsura, YA | 1 |
| Gracheva, EV; Kovalenko, AL; Malkova, VM; Trashkov, AP; Tsygan, NV; Vasiliev, AG; Yakovleva, VA | 1 |
| Belova, LA; Burenichev, DV; Chichanovskaya, LV; Golikov, KV; Kabaeva, EN; Kolotik-Kameneva, OY; Kovalenko, AL; Mashin, VV; Mazina, NK; Nazarov, MV; Rumyantsevа, SA; Salnikov, MV; Sherman, MA; Silinа, EV; Stupin, VA; Tsukurova, LA; Zhilina, EA | 1 |
| Kovalenko, AL; Markevich, LB; Markevich, PS; Plekhanov, AN | 1 |
| Fedorkiv, MB | 1 |
| Kuptsova, TA; Lysev, SF; Maksimova, MN; Shcherbakova, YG; Strukov, VI | 1 |
| Anisimova, TI; Bondarchuk, YL; Chutko, LS; Rozhkova, AV; Surushkina, SY; Yakovenko, EA | 1 |
| Beloborodov, VA; Borisova, VM; Golub, IY; Kur'yanov, AA; Sorokina, LV | 1 |
| Antipenko, EA; Derugina, AV; Gustov, AV | 1 |
| Kovalchuk, VV | 1 |
| Brikman, IN; Gatskikh, IV; Kuznetsov, MN; Petrova, MM; Shalda, TP; Shul'min, AV; Varygina, EL; Veselova, OF | 1 |
| Bagnenko, SF; Dubikaitis, PA; Dzhusoev, IG; Lapitskiy, AV; Sa'dulaev, DSh | 1 |
| Belova, LA; Belova, NV; Kolotik-Kameneva, OY; Mashin, VV | 1 |
| Ashour, АZ; Belov, VG; Ershov, EV; Kovalenko, AL; Parfyonov, SA; Parfyonov, UA; Talikova, EV; Tuchin, IA | 1 |
| Belov, VG; Ershov, EV; Haritonova, TV; Kovalenko, AL; Parfyenov, SA; Parfyenov, UA; Sapozhnikov, KV; Skripko, VD; Zakharov, KI | 1 |
| Kharitonova, T; Kovalenko, A; Myhaloyko, I; Skrypko, V; Zaplutanov, V | 1 |
| Belov, VG; Kovalenko, AL; Parfenov, SA; Parfenov, YA; Vasilevskaya, MA; Zaplutanov, VA | 1 |
| Bitchuk, N; Dubivska, S; Grigorov, Y; Kudinova, O | 1 |
| Churpiy, I; Kovalenko, A; Pasko, A; Skrypko, V; Zaplutanov, V | 1 |
| Dorovskikh, VA; Li, ON; Shtarberg, MA; Simonova, NV | 1 |
| Sataeva, TP; Tret'yakova, OS; Zadnipryanyi, IV | 1 |
| Antipenko, EA; Deryugina, AV; Krylov, VN | 1 |
| Anokhina, RA; Dorovskikh, VA; Pereverzev, DI; Simonova, NV | 1 |
| Kovalenko, A; Parfenov, S; Parfenov, Y; Sapozhnikov, K; Vasilevskaya, M; Zaplutanov, V | 1 |
| Cherebillo, VY; Malkhozova, AM; Paltsev, AA; Petrova, AO; Rutkovskiy, RV; Savvina, IA; Sergeev, AV; Zabrodskaya, YM | 1 |
| Adleba, LZ; Lebedeva, EA; Lokhmanova, VV; Scoblo, ML | 1 |
| Bazhanova, ED; Sokolova, YO; Teplyi, DL | 1 |
| Belov, VG; Ershov, EV; Parfyonov, SA; Parfyonov, UA; Sapozhnikov, KV; Zakharov, IK; Zaplutanov, VA | 1 |
| Esipov, AV; Ivolgin, AF; Kalyagin, IE; Karakozov, AG; Katenko, SV; Kazakov, SP; Khritinin, DF; Levchenko, OB; Molodova, AI | 1 |
| Chutko, LS; Majidova, EN; Rozhkova, AV; Surushkina, SY; Volov, MB; Yakovenko, EA; Zhukovskaya, NV | 1 |
| Egorova, ES; Gorelik, EY; Markova, KV; Skripchenko, NV; Vilnits, AA | 1 |
| Bazhenov, VA; Poltavskaya, TS; Volojanin, AV | 1 |
| Borisov, AS; Lavrick, SY; Mikhalevich, IM; Shprakh, VV | 1 |
| Anisimov, VN; Bazhanova, ED; Sokolova, YO; Teply, DL | 1 |
| Neymark, MI; Rakhmonov, AA; Shmelev, VV | 1 |
| Bolevich, SB; Parfenov, VA; Rumyantceva, SA; Silina, EV; Stupin, VA | 1 |
| Belkin, AA; Kovalenko, AL; Leiderman, IN; Parfenov, SA; Rizakhanova, OA; Sapozhnikov, KV | 1 |
| Darenskaya, MA; Grebenkina, LA; Kolesnikov, SI; Kolesnikova, LI; Okhremchuk, LV; Seminskii, IZ | 1 |
| Elkin, AA; Kovalenko, AL; Parfenov, SA; Parfenov, YA; Rizakhanov, DM; Rizakhanova, OA; Sapozhnikov, KV | 1 |
| Elkin, AA; Kovalenko, AL; Parfenov, SA; Parfenov, YA; Rizakhanova, OA; Sapozhnikov, KV; Vasilevskaya, MA | 1 |
| Bairova, KI; Petrikeeva, AE; Putilina, MV; Shabalina, NI; Teplova, NV | 1 |
| Ekusheva, EV; Rizakhanova, OA; Voitenkov, VB | 1 |
| Kataeva, NG; Korotkova, EI; Svetlik, MV; Voronova, OA; Zamoshchina, TA | 1 |
| Kovalenko, AL; Strokov, IA; Trakhtenberg, YA | 1 |
| Belova, LA; Dolgova, DR; Kruglova, LR; Kuvayskaya, AA; Mashin, VV; Plaksina, TD; Sukhikh, SS | 1 |
| Gavrilova, NY; Kamaeva, EA; Lemeshevskaia, OI; Lukashenko, MV; Soprun, LA | 1 |
1 review(s) available for niacinamide and inosine diphosphate
| Article | Year |
|---|---|
[Pathogenetic correction of metabolic disturbances in chronic liver affections].
Topics: Apoptosis; Chronic Disease; Drug Combinations; Flavin Mononucleotide; Glutathione Disulfide; Hepatitis C, Chronic; Humans; Inosine Diphosphate; Lipid Peroxidation; Liver Diseases; Niacinamide; Protective Agents; Succinates | 2012 |
64 trial(s) available for niacinamide and inosine diphosphate
| Article | Year |
|---|---|
[Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury].
Topics: Adolescent; Adult; Brain Injuries; Drug Combinations; Flavin Mononucleotide; gamma-Aminobutyric Acid; Humans; Inosine Diphosphate; Middle Aged; Niacinamide; Succinates; Treatment Outcome; Young Adult | 2010 |
[Cytoflavin in total intravenous anesthesia].
Topics: Adult; Anesthesia Recovery Period; Anesthesia, Intravenous; Cholecystectomy, Laparoscopic; Double-Blind Method; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Gallstones; Humans; Injections, Intravenous; Inosine Diphosphate; Male; Middle Aged; Monitoring, Intraoperative; Niacinamide; Prospective Studies; Succinates; Treatment Outcome; Young Adult | 2010 |
[Effect of early correction of energy and free-radical homeostasis on the clinical-morphological presentation of cerebral infarction].
Topics: Adult; Aged; Antioxidants; Biomarkers; Cerebral Infarction; Drug Combinations; Energy Metabolism; Female; Flavin Mononucleotide; Free Radicals; Homeostasis; Humans; Inosine Diphosphate; Magnetic Resonance Imaging; Male; Middle Aged; Niacinamide; Oxidative Stress; Succinates; Treatment Outcome | 2010 |
[Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness].
Topics: Aged; Chronic Disease; Drug Combinations; Female; Flavin Mononucleotide; Hearing Loss, Sensorineural; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Speech Perception; Succinates; Treatment Outcome | 2010 |
[Cytoflavin in polychemotherapy of breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Middle Aged; Niacinamide; Quality of Life; Succinates | 2010 |
[Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy].
Topics: Adolescent; Adult; Antioxidants; Burns; Drug Combinations; Drug Therapy, Combination; Female; Flavin Mononucleotide; Humans; Hypoxia, Brain; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Oxidative Stress; Succinates; Treatment Outcome; Young Adult | 2010 |
[Efficacy of cytoflavin in patients in the acute ischemic stroke].
Topics: Aged; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Magnetic Resonance Imaging; Male; Middle Aged; Niacinamide; Recovery of Function; Severity of Illness Index; Stroke; Succinates; Treatment Outcome | 2010 |
[Current approaches to cerebroprotective treatment of premature newborns in reanimation and intensive care departments].
Topics: Drug Combinations; Female; Fetal Hypoxia; Flavin Mononucleotide; Glial Fibrillary Acidic Protein; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Inosine Diphosphate; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Myelin Basic Protein; Niacinamide; Resuscitation; Succinates; Treatment Outcome | 2011 |
[Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: a role of metabolic and antioxidant therapy].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antioxidants; Autoantibodies; Cognition; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Lipid Peroxidation; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Myelin Sheath; Niacinamide; Pentoxifylline; Succinates; Vitamin B Complex; Young Adult | 2011 |
[Oxidative stress and combined antioxidant energy correction in the treatment of periodontitis].
Topics: Adult; Aged; Animals; Antioxidants; Calcium; Cholecalciferol; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Energy Metabolism; Female; Flavin Mononucleotide; Free Radicals; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Oxidative Stress; Periodontitis; Rats; Rats, Wistar; Succinates | 2011 |
[The complex energy correction of chronic brain ischemia].
Topics: Antioxidants; Brain Ischemia; Cognition; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Niacinamide; Succinates; Treatment Outcome | 2011 |
[Correction of central nervous system energy processes in children with the minimal cerebral dysfunction].
Topics: Attention Deficit Disorder with Hyperactivity; Brain; Child; Child, Preschool; Drug Combinations; Energy Metabolism; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Niacinamide; Regional Blood Flow; Succinates | 2011 |
[The use of cytoflavin for the treatment of chronic brucellosis].
Topics: Adult; Brucellosis; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Succinates; Treatment Outcome | 2011 |
[Antioxidant protection in surgical correction of inborn heart disease with the use of artificial circulation].
Topics: Antioxidants; Cardiotonic Agents; Child, Preschool; Drug Combinations; Drug Monitoring; Extracorporeal Circulation; Female; Flavin Mononucleotide; Heart Defects, Congenital; Humans; Infant; Inosine Diphosphate; Male; Monitoring, Intraoperative; Myocytes, Cardiac; Niacinamide; Oxygen Consumption; Succinates; Treatment Outcome | 2011 |
[Clinical-encephalographic evaluation of preterm children treated with cytoflavin during the first year of life].
Topics: Child Development; Drug Combinations; Electroencephalography; Female; Flavin Mononucleotide; Humans; Hypoxia-Ischemia, Brain; Infant; Infant, Newborn; Infant, Premature; Inosine Diphosphate; Intensive Care, Neonatal; Male; Niacinamide; Psychomotor Disorders; Succinates | 2011 |
[Postoperative correction of the methabolism of the single lung after pulmonectomy].
Topics: Adult; Aged; Drug Combinations; Enteral Nutrition; Flavin Mononucleotide; Follow-Up Studies; Humans; Infusions, Intravenous; Inosine Diphosphate; Lung; Lung Neoplasms; Metabolic Diseases; Middle Aged; Niacinamide; Pneumonectomy; Postoperative Care; Prospective Studies; Recovery of Function; Respiration; Respiratory Function Tests; Succinates; Treatment Outcome | 2011 |
[Positive effect of cytoflavin on metabolic status changes in patients with burn disorder].
Topics: Adult; Antioxidants; Burns; Case-Control Studies; Catalase; Drug Combinations; Female; Flavin Mononucleotide; Heat-Shock Response; Humans; Inosine Diphosphate; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Niacinamide; Succinates; Superoxide Dismutase; Vitamin E | 2011 |
[Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
Topics: Antioxidants; Brain Ischemia; Chronic Disease; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Neuroprotective Agents; Niacinamide; Succinates | 2011 |
[Effect of cytoflavin on the recovery of cognitive function after the cardiaс surgery with artificial blood circulation].
Topics: Assisted Circulation; Cognition; Cognition Disorders; Drug Combinations; Female; Flavin Mononucleotide; Heart Valve Diseases; Humans; Inosine Diphosphate; Male; Middle Aged; Myocardial Ischemia; Niacinamide; Postoperative Complications; Succinates; Treatment Outcome | 2011 |
[Cytoflavin in the complex treatment of neuroinfections in children].
Topics: Adolescent; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Encephalitis, Viral; Female; Flavin Mononucleotide; Humans; Infant; Infant, Newborn; Inosine Diphosphate; Male; Meningitis, Bacterial; Niacinamide; Succinates | 2011 |
[Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period].
Topics: Adult; Antioxidants; Drug Combinations; Endotoxemia; Female; Flavin Mononucleotide; Free Radicals; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Peritonitis; Postoperative Complications; Postoperative Period; Succinates | 2011 |
[Experience of cytoflavin administration for treating acute carbon monoxide poisoning].
Topics: Adult; Carbon Monoxide; Carbon Monoxide Poisoning; Carboxyhemoglobin; Case-Control Studies; Drug Administration Schedule; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypoxia; Infusions, Intravenous; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Retrospective Studies; Russia; Severity of Illness Index; Succinates; Survival Rate; Unconsciousness | 2011 |
[Correction of nonspecific damages in acute poisoning of substance from the group of opiate drug in patients in critical condition].
Topics: Acute Disease; Adult; Analgesics, Opioid; Critical Illness; Female; Humans; Inosine Diphosphate; Length of Stay; Male; Neurotoxicity Syndromes; Niacinamide; Opioid-Related Disorders; Riboflavin; Vitamin B Complex | 2011 |
[Pharmacologic correction of hypoxia in patients with acute cerebral failure due to acute poisoning with carbon monoxide and combustion products].
Topics: Acute Disease; Adult; Blood Gas Analysis; Carbon Monoxide Poisoning; Combined Modality Therapy; Critical Care; Drug Combinations; Drug Therapy, Combination; Female; Fires; Flavin Mononucleotide; Humans; Hypoxia; Hypoxia, Brain; Inosine Diphosphate; Male; Neuroprotective Agents; Niacinamide; Oxygen; Respiration, Artificial; Succinates; Treatment Outcome | 2012 |
[The use of cytoflavin in the complex treatment of patients with tick-borne encephalitis].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Encephalitis, Tick-Borne; Female; Flavin Mononucleotide; Humans; Infant; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Succinates; Treatment Outcome; Young Adult | 2012 |
[Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
Topics: Adult; Brain Damage, Chronic; Drug Administration Schedule; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypertension; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Quality of Life; Succinates; Treatment Outcome; Venous Insufficiency | 2012 |
[Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
Topics: Brain; Brain Ischemia; Chronic Disease; Drug Combinations; Female; Flavin Mononucleotide; Hemodynamics; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Psychiatric Status Rating Scales; Regional Blood Flow; Succinates; Treatment Outcome | 2012 |
[Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
Topics: Administration, Intravenous; Aged; Antioxidants; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Magnetic Resonance Imaging; Male; Metabolic Syndrome; Middle Aged; Neuroprotective Agents; Niacinamide; Piracetam; Stroke; Succinates; Treatment Outcome | 2012 |
[The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia].
Topics: Adult; Aged; Combined Modality Therapy; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Myasthenia Gravis; Niacinamide; Ozone; Succinates; Treatment Outcome; Young Adult | 2013 |
[Cytoflavin in the detoxification of alcohol-dependent patients].
Topics: Adult; Alcoholism; Drug Combinations; Ethanol; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Inactivation, Metabolic; Inosine Diphosphate; Niacinamide; Substance Withdrawal Syndrome; Succinates; Treatment Outcome | 2013 |
[Treatment of alcohol addiction syndrome with cytoflavin].
Topics: Adult; Alcoholism; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Niacinamide; Succinates; Syndrome; Treatment Outcome | 2013 |
[Correction of energy homeostasis in the acute period of concomitant brain injury].
Topics: Adolescent; Adult; Brain Injuries; Critical Care; Drug Combinations; Energy Metabolism; Female; Flavin Mononucleotide; Homeostasis; Hospital Mortality; Humans; Inosine Diphosphate; Length of Stay; Male; Middle Aged; Niacinamide; Prospective Studies; Respiration, Artificial; Succinates; Treatment Outcome; Young Adult | 2013 |
[Event-related potentials in moderate cognitive impairment in patients with chronic cerebral ischemia treated with cytoflavin].
Topics: Acoustic Stimulation; Brain Ischemia; Cognition; Cognitive Dysfunction; Drug Combinations; Evoked Potentials; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Inosine Diphosphate; Male; Middle Aged; Neuropsychological Tests; Niacinamide; Succinates; Treatment Outcome | 2013 |
[Investigation of the effects of cytoflavin on symptoms of depression and autonomic dysfunction in patients with organic depressive disorder].
Topics: Adult; Antidepressive Agents; Autonomic Nervous System Diseases; Depression; Depressive Disorder; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Nootropic Agents; Sex Factors; Succinates | 2013 |
[Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
Topics: Acute Disease; Adult; Brain Diseases, Metabolic; Drug Combinations; Female; Flavin Mononucleotide; Hemodynamics; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Poisoning; Succinates | 2013 |
[Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury].
Topics: Adolescent; Adult; Aged; Brain Injuries; Critical Care; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Prospective Studies; Succinates; Time Factors | 2014 |
[The influence of citoflavin on molecular mechanisms of hypertensive encephalopathy development in patients with systolic arterial hypertension].
Topics: Aged; Aged, 80 and over; Amlodipine; Aspirin; Atorvastatin; Blood Pressure; Blood Proteins; Drug Combinations; Drug Therapy, Combination; Echocardiography; Female; Flavin Mononucleotide; Hemodynamics; Heptanoic Acids; Humans; Hypertension; Hypertensive Encephalopathy; Inosine Diphosphate; Male; Neuroprotective Agents; Niacinamide; Pyrroles; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Succinates; Systole; Tetrazoles; Valine; Valsartan | 2014 |
[Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
Topics: Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Energy Metabolism; Female; Flavin Mononucleotide; Headache; Humans; Hypertensive Encephalopathy; Inosine Diphosphate; Male; Middle Aged; Neurocirculatory Asthenia; Niacinamide; Pain Measurement; Polysomnography; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Succinates; Treatment Outcome; Visual Analog Scale; Vitamin B Complex | 2014 |
[Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
Topics: Aged; Anti-Bacterial Agents; Antioxidants; Arteries; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Combinations; Drug Monitoring; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Peripheral Arterial Disease; Severity of Illness Index; Succinates; Treatment Outcome; Vascular Calcification; Vasodilator Agents | 2014 |
[Efficacy of antioxidant energocorreсtion in brain infarction (results of a multicenter randomized trial)].
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Brain Infarction; Brain Ischemia; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Succinates; Treatment Outcome | 2014 |
[The use of neurometabolic treatment in the complex rehabilitation in poststroke patients].
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Emotions; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Prospective Studies; Social Adjustment; Stroke; Stroke Rehabilitation; Succinates | 2014 |
[Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction].
Topics: Aged; Antioxidants; Ascorbic Acid; Cerebral Infarction; Cognition; Drug Administration Schedule; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Precision Medicine; Psychological Tests; Russia; Severity of Illness Index; Succinates; Treatment Outcome | 2015 |
[Gerontological trends of contemporary forms of alcohol dependence. Approaches to full compensation and rehabilitation].
Topics: Aged; Alcoholism; Comorbidity; Cytokines; Drug Combinations; Drug Therapy, Combination; Flavin Mononucleotide; Humans; Inosine Diphosphate; Interferon-alpha; Male; Meglumine; Middle Aged; Niacinamide; Quality of Life; Succinates; Surveys and Questionnaires; Treatment Outcome | 2014 |
[Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].
Topics: Aged; Antioxidants; Craniocerebral Trauma; Critical Care; Drug Combinations; Flavin Mononucleotide; Glasgow Coma Scale; Humans; Inosine Diphosphate; Lipid Peroxides; Middle Aged; Neuroprotective Agents; Niacinamide; Prospective Studies; Succinates; Treatment Outcome | 2014 |
[The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin].
Topics: Aged; Aging; Blood Coagulation; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain; Cardiovascular System; Cerebrovascular Circulation; Cohort Studies; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypertension; Inosine Diphosphate; Lipids; Male; Niacinamide; Prospective Studies; Proteome; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Succinates; Ultrasonography, Doppler, Transcranial | 2014 |
[Modern methods of energy homeostasis correction in elderly patients].
Topics: Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Energy Metabolism; Female; Flavin Mononucleotide; Homeostasis; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Prospective Studies; Severity of Illness Index; Stroke; Succinates; Treatment Outcome | 2014 |
[Cytoflavin® effect on endothelium function and cerebral hemodynamics in patients with hypertensive enceplalopathy].
Topics: Adult; Aged; Brain; Cerebral Arteries; Drug Administration Schedule; Drug Combinations; Endothelium, Vascular; Female; Flavin Mononucleotide; Hemodynamics; Humans; Hypertensive Encephalopathy; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Succinates; Ultrasonography | 2014 |
[THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA].
Topics: Adult; Aged; Antihypertensive Agents; Arterial Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Infusions, Intravenous; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Retrospective Studies; Succinates; Treatment Outcome | 2015 |
[The effect of the succinic acid preparation on the dynamics of neurological and emotional disturbances in patients with dorsopathy].
Topics: Adult; Affective Symptoms; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Low Back Pain; Male; Middle Aged; Neuromuscular Agents; Niacinamide; Succinates; Succinic Acid; Young Adult | 2015 |
[Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Brain Infarction; Drug Combinations; Energy Metabolism; Female; Flavin Mononucleotide; Humans; Infusions, Intravenous; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Russia; Succinates; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[Efficacy of cytoflavin in the treatment of hypoxic-ischemic lesions of the nervous system in 1-month old children with transient neonatal hypothyroidism].
Topics: Antioxidants; Brain Ischemia; Congenital Hypothyroidism; Drug Combinations; Female; Flavin Mononucleotide; Humans; Infant; Infant, Newborn; Inosine Diphosphate; Male; Motor Activity; Niacinamide; Succinates; Treatment Outcome | 2015 |
[The efficacy of cytoflavin in the treatment of burnout syndrome].
Topics: Adult; Antioxidants; Burnout, Professional; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Niacinamide; Succinates; Syndrome; Treatment Outcome | 2015 |
[COGNITIVE ABNORMALITIES IN POSTOPERATIVE PERIOD OF THYROID SURGERY].
Topics: Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Hyperparathyroidism; Imidazoles; Inosine Diphosphate; Niacinamide; Postoperative Complications; Prognosis; Prospective Studies; Succinates; Tetrazoles; Thyroidectomy | 2015 |
[An effect of cytoprotective therapy on stress resistance and compensatory abilities of patients with chronic cerebral ischemia].
Topics: Adult; Antioxidants; Brain Ischemia; Chronic Disease; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Stress, Physiological; Succinates; Treatment Outcome | 2015 |
[EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
Topics: Adult; Aged; Cognition Disorders; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Succinates | 2015 |
[The effectiveness of the combined use of energomonitor antioxidant and cognitive psychotherapy in the treatment of generalized periodontitis in elderly patients].
Topics: Aged; Aged, 80 and over; Antioxidants; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Middle Aged; Niacinamide; Periodontitis; Succinates; Treatment Outcome | 2016 |
[EFFICACY OF CYTOFLAVIN IN COMPLEX TREATMENT OF DIABETIC FOOT SYNDROME].
Topics: Antioxidants; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Combinations; Female; Flavin Mononucleotide; Foot; Humans; Inosine Diphosphate; Leg; Male; Monckeberg Medial Calcific Sclerosis; Neuroprotective Agents; Niacinamide; Succinates | 2017 |
[SUBSTANTIATION OF INDICATIONS FOR BIOFEEDBACK THERAPY AND CYTOFLAVIN APPLICATION IN TREATMENT OF OSTEOCHONDROSIS NEUROLOGICAL COMPLICATIONS IN ELDERLY PATIENTS].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biofeedback, Psychology; Combined Modality Therapy; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Middle Aged; Nervous System Diseases; Niacinamide; Physical Therapy Modalities; Retrospective Studies; Spinal Osteochondrosis; Succinates; Surveys and Questionnaires; Treatment Outcome | 2018 |
[Clinical efficacy of neurometabolic therapy of dissomical disorders in asthenic syndrome].
Topics: Administration, Oral; Antioxidants; Asthenia; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Melatonin; Niacinamide; Sleep Wake Disorders; Succinates; Syndrome; Treatment Outcome | 2019 |
[Possibilities of using Cytoflavin in the treatment of cognitive and emotional disorders in patients with tension headaches].
Topics: Adolescent; Adult; Anxiety; Cognition; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Middle Aged; Mood Disorders; Niacinamide; Succinates; Tension-Type Headache; Young Adult | 2019 |
[The efficacy of metabolic treatment in the early recovery period of patients with ischemic stroke].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Brain Ischemia; Cognition; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Stroke; Stroke Rehabilitation; Succinates; Treatment Outcome; Young Adult | 2020 |
Early predictive blood markers of hemorrhagic stroke - influence of cytoflavin therapy.
Topics: Aged; Animals; Antioxidants; Biomarkers; Blood Glucose; Brain; Drug Combinations; Female; Flavin Mononucleotide; Hemorrhagic Stroke; Hospital Mortality; Humans; Inosine Diphosphate; L-Lactate Dehydrogenase; Lactic Acid; Magnetic Resonance Imaging; Male; Malondialdehyde; Middle Aged; Niacinamide; Oxidative Stress; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Succinates; Treatment Outcome | 2021 |
[The result of prospective randomized study CITADEL - the efficacy and safety of drug cytoflavin in postcovid rehabilitation].
Topics: Adult; COVID-19; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Prospective Studies; Retrospective Studies; SARS-CoV-2; Sleep Quality; Succinates; Treatment Outcome | 2021 |
[Efficacy and safety of Cytoflavin in the treatment of diabetic polyneuropathy: results of a multicenter, double-blind, placebo-controlled, randomized CYLINDER study].
Topics: Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Inosine Diphosphate; Niacinamide | 2023 |
94 other study(ies) available for niacinamide and inosine diphosphate
| Article | Year |
|---|---|
Effects of cytoflavin and neuronol on morphological changes in the brain and survival of rats with ischemic disturbances in cerebral blood flow.
Topics: Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Male; Neuroprotective Agents; Niacinamide; Rats; Regional Blood Flow; Reperfusion Injury; Succinates; Succinic Acid; Survival Rate | 2004 |
Neuroprotective effect of cytoflavin during compression injury of the spinal cord.
Topics: Animals; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Male; Neuroprotective Agents; Niacinamide; Rats; Spinal Cord Compression; Spinal Cord Injuries; Succinates | 2005 |
Effect of cerebronorm on energy metabolism and lipid peroxidation in rat brain during hypoxia.
Topics: Animals; Brain; Energy Metabolism; Hypoxia; Inosine Diphosphate; Lipid Peroxidation; Male; Mitochondria; Niacinamide; Oxidative Phosphorylation; Rats; Riboflavin; Succinic Acid | 2007 |
[Correction of a reperfusion dysfunction in acute intestinal obstruction].
Topics: Acute Disease; Animals; Digestive System Surgical Procedures; Disease Models, Animal; Dogs; Drug Combinations; Flavin Mononucleotide; Humans; Infusions, Intravenous; Inosine Diphosphate; Intestinal Obstruction; Intestine, Small; Male; Middle Aged; Niacinamide; Rabbits; Reperfusion Injury; Succinates; Treatment Outcome | 2008 |
[Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
Topics: Animals; Antioxidants; Drug Combinations; Flavin Mononucleotide; Free Radicals; Inosine Diphosphate; Intestine, Small; Lipid Peroxidation; Male; Mitochondria; Muscle, Smooth; Niacinamide; Peritonitis; Postoperative Period; Rabbits; Succinates; Suppuration | 2010 |
[Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy].
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Cytoprotection; Doxorubicin; Drug Combinations; Erythrocytes; Flavin Mononucleotide; Glutathione; Inosine Diphosphate; Lipid Peroxidation; Male; Myocardium; Niacinamide; Rats; Succinates | 2010 |
[Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
Topics: Brain; Cerebrovascular Circulation; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Succinates; Ultrasonography; Vertebrobasilar Insufficiency | 2010 |
[Correction of metabolic disturbances in cancer patients in the early postanesthesia period].
Topics: Adult; Aged; Anesthesia, General; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Hypoxia; Infusions, Intravenous; Inosine Diphosphate; Malondialdehyde; Middle Aged; Neoplasms; Niacinamide; Postoperative Period; Succinates; Treatment Outcome | 2010 |
[Perspectives of treatment of patients with ischemic stroke: the place and the role of cytoflavin].
Topics: Aged; Antioxidants; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Niacinamide; Peptides; Stroke; Succinates; Treatment Outcome | 2010 |
[Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Topics: Antioxidants; Central Nervous System Infections; Drug Combinations; Electroencephalography; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Metalloproteins; Neuroprotective Agents; Niacinamide; Succinates; Superoxide Dismutase | 2010 |
[Pharmacological correction of hypoxic and free-radical disorders in patients with acute myocardial infarction complicated by acute heart failure].
Topics: Acute Disease; Critical Care; Drug Combinations; Flavin Mononucleotide; Fluorocarbons; Free Radicals; Heart Failure; Humans; Hypoxia; Inosine Diphosphate; Inpatients; Length of Stay; Lipid Peroxidation; Myocardial Infarction; Niacinamide; Succinates | 2010 |
[Efficacy of cytoflavin in the treatment of chronic cerebral ischemia].
Topics: Asthenia; Brain Ischemia; Chronic Disease; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Multicenter Studies as Topic; Neuropsychological Tests; Niacinamide; Quality of Life; Randomized Controlled Trials as Topic; Succinates | 2010 |
[Efficacy of cytoflavine in treating traumatic toxicosis].
Topics: Animals; Blood Circulation; Blood Pressure; Crush Syndrome; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Lactic Acid; Male; Niacinamide; Oxygen Consumption; Pyruvic Acid; Rats; Respiration; Succinates; Time Factors; Water-Electrolyte Balance | 2010 |
[Current approaches to treating acute gastroduodenal ulcer bleedings].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; APACHE; Drug Combinations; Duodenal Ulcer; Female; Flavin Mononucleotide; Gastric Mucosa; Humans; Inosine Diphosphate; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Niacinamide; Peptic Ulcer Hemorrhage; Stomach Ulcer; Succinates; Young Adult | 2010 |
[Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions].
Topics: Clinical Trials as Topic; Critical Care; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Multicenter Studies as Topic; Neuroprotective Agents; Niacinamide; Pharmaceutical Solutions; Resuscitation; Succinates | 2010 |
[The use of cytoflavin in combined neurometabolic therapy of acute cerebral insufficiency associated with acute poisoning with neurotropic poisons].
Topics: Acute Disease; CD3 Complex; CD4 Antigens; CD8 Antigens; Coma; Critical Illness; Drug Combinations; Flavin Mononucleotide; Humans; Hypoxia, Brain; Inosine Diphosphate; Lymphocytes; Neuroprotective Agents; Neurotoxicity Syndromes; Niacinamide; Poisoning; Receptors, Interleukin-2; Respiration, Artificial; Succinates | 2010 |
Comparative efficiency of succinate-containing antihypoxants in traumatic toxicosis.
Topics: Animals; Antioxidants; Drug Combinations; Endotoxemia; Flavin Mononucleotide; Inosine Diphosphate; Ischemia; Male; Meglumine; Niacinamide; Nitrogen; Potassium; Rats; Rats, Wistar; Succinates | 2010 |
[Correcting posthypoxic damage of myocardium in newborns with cerebral ischemia].
Topics: Brain Ischemia; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Heart; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Inosine Diphosphate; Male; Myocardial Contraction; Myocardium; Niacinamide; Succinates | 2010 |
[Using cytoflavin for correcting x-ray contrasting agent-induced nephropathy].
Topics: Animals; Contrast Media; Cytoprotection; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Iohexol; Kidney Diseases; Male; Niacinamide; Rats; Succinates | 2010 |
[Experimental study on cytoflavin pharmacological correction of cyclophosphamide-induced toxic affections of the liver and kidneys].
Topics: Animals; Antineoplastic Agents, Alkylating; Antioxidants; Cyclophosphamide; Cytoprotection; Drug Combinations; Flavin Mononucleotide; Glutathione; Inactivation, Metabolic; Injections, Intraperitoneal; Inosine Diphosphate; Kidney; Lipid Peroxidation; Liver; Male; Niacinamide; Rats; Succinates | 2010 |
[Antioxidant therapy in discirculatory encephalopathy].
Topics: Antioxidants; Brain Ischemia; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Succinates; Treatment Outcome | 2010 |
[The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
Topics: Aged; Arteriosclerosis Obliterans; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Infusions, Intravenous; Inosine Diphosphate; Leg; Male; Middle Aged; Niacinamide; Succinates; Treatment Outcome; Walking | 2011 |
[Clinical efficacy of cytoflavin in the combined treatment of patients during acute phase of ischemic stroke].
Topics: Acute Disease; Adult; Aged; Brain Ischemia; Drug Combinations; Electroencephalography; Flavin Mononucleotide; Follow-Up Studies; Humans; Inosine Diphosphate; Middle Aged; Niacinamide; Succinates; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[Antioxidant and membranoprotector treatment of chronic pyelonephritis].
Topics: Adult; Antioxidants; Azotemia; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Erythrocyte Membrane; Erythrocytes; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Lipid Peroxidation; Lipid Peroxides; Male; Middle Aged; Niacinamide; Phospholipids; Pyelonephritis; Succinates | 2011 |
[Antioxidant protection as a component of anesthetic management cancer patients].
Topics: Adaptation, Physiological; Aged; Anesthetics, Combined; Antioxidants; Balanced Anesthesia; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Lipid Peroxidation; Male; Monitoring, Physiologic; Neoplasms; Neoplastic Processes; Niacinamide; Oxidative Stress; Perioperative Period; Protective Agents; Stress, Physiological; Succinates; Surgical Procedures, Operative; Treatment Outcome | 2011 |
[Pharmacologic neuroprotection of the brain in carotid artery surgeries].
Topics: Aged; Brain; Carotid Arteries; Carotid Stenosis; Drug Combinations; Endarterectomy, Carotid; Female; Flavin Mononucleotide; Heme; Humans; Hypoxia-Ischemia, Brain; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Reperfusion Injury; Succinates | 2011 |
[Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis].
Topics: Acute Disease; Animals; Antioxidants; Disease Models, Animal; Drug Combinations; Flavin Mononucleotide; Guinea Pigs; Injections, Intraperitoneal; Inosine Diphosphate; Niacinamide; Oxygen; Oxygen Consumption; Pancreas; Pancreatitis; Partial Pressure; Picolines; Succinates; Treatment Outcome | 2011 |
[Pharmacological neuroprotection against brain damage in ischemiai/reperfusion experiment].
Topics: Animals; Brain; Drug Combinations; Drug Evaluation, Preclinical; Eosine Yellowish-(YS); Flavin Mononucleotide; Glycine; Hematoxylin; Heme; Hemostasis; Immunohistochemistry; Inosine Diphosphate; Male; Necrosis; Neurons; Neuroprotective Agents; Niacinamide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Picolines; Rats; Rats, Inbred Strains; Reperfusion Injury; Succinates; TNF-Related Apoptosis-Inducing Ligand | 2011 |
[Prevention of cognitive dysfunction in patients operated on thyroid gland].
Topics: Adolescent; Adult; Aged; Antioxidants; Cognition Disorders; Drug Combinations; Drug Monitoring; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Intraoperative Care; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Niacinamide; Postoperative Care; Postoperative Complications; Recovery of Function; Succinates; Thyroid Diseases; Thyroid Gland; Thyroidectomy; Treatment Outcome | 2011 |
[Methods for the prevention and treatment of toxico-hypoxic encephalopathy in patients with acute severe poisoning].
Topics: Acute Disease; Adult; Antidotes; Drug Combinations; Electroencephalography; Flavin Mononucleotide; Humans; Hypoxia, Brain; Inosine Diphosphate; Neuroprotective Agents; Niacinamide; Poisoning; Severity of Illness Index; Succinates; Vitamin B Complex | 2011 |
[Immune system disorders and their correction in critically ill patients with toxic and hypoxic encephalopathy].
Topics: Blood Cell Count; Clozapine; Critical Illness; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypoxia, Brain; Immune System; Inosine Diphosphate; Male; Neurotoxicity Syndromes; Niacinamide; Poisoning; Succinates | 2012 |
[Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning].
Topics: Central Nervous System; Coma; Drug Combinations; Electroencephalography; Female; Flavin Mononucleotide; Glucose; Humans; Hypoxia, Brain; Inosine Diphosphate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Niacinamide; Succinates | 2012 |
[Metabolic immunocorrection treatment of experimental widespread purulent peritonitis].
Topics: Animals; Cardiotonic Agents; Cell Movement; Disease Models, Animal; Drug Combinations; Escherichia coli; Flavin Mononucleotide; Groin; Humans; Inosine Diphosphate; Lymph Nodes; Lymphocytes; Male; Monocytes; Neuroprotective Agents; Neutrophils; Niacinamide; Peritonitis; Peyer's Patches; Phosphocreatine; Postoperative Period; Rabbits; Spleen; Succinates; Suppuration | 2012 |
[The efficacy of cytoflavin used for the correction of psychoemotional and neuroimmune disturbances in the patients presenting with eczema].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Drug Combinations; Eczema; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Succinates; Young Adult | 2012 |
[Pharmacological correction of hypoxia in patients with severe carbon monoxide poisoning].
Topics: Adult; Carbon Monoxide; Carbon Monoxide Poisoning; Drug Combinations; Female; Fires; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Oxygen; Oxygen Consumption; Respiration, Artificial; Succinates | 2012 |
[Neuroimmune aspects of the pathogenesis and nitric oxide negative effects modifying the pathogenetic treatment of tick-borne infections].
Topics: Adult; Animals; Biomarkers; Central Nervous System; Cytokines; Drug Combinations; Encephalitis, Tick-Borne; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Ixodes; Lyme Neuroborreliosis; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Nitric Oxide; Succinates | 2012 |
[Correction of protein-lipid composition in liver mitochondria during experimental widespread purulent peritonitis].
Topics: Animals; Cholesterol; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Male; Mitochondria, Liver; Mitochondrial Membranes; Niacinamide; Peritonitis; Phosphocreatine; Phospholipids; Proteins; Rabbits; Succinates; Suppuration | 2012 |
[Correction of mnestico-intellectual disturbances in the somatogenic phase of acute poisoning with a mixture of psychotropic drugs].
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Psychotropic Drugs; Succinates; Young Adult | 2012 |
[Course of free radical processes and prognosis of ischemic and hemorrhagic stroke].
Topics: Aged; Antioxidants; Biomarkers; Brain Ischemia; Drug Combinations; Female; Flavin Mononucleotide; Free Radicals; Humans; Inosine Diphosphate; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Malondialdehyde; Middle Aged; Niacinamide; Prognosis; Stroke; Succinates | 2011 |
[The immune activity of cytoflavine in the treatment of the diffuse septic peritonitis].
Topics: Adult; Cell Movement; Combined Modality Therapy; Drug Combinations; Female; Flavin Mononucleotide; Humans; Immunity, Cellular; Inosine Diphosphate; Leukocytes, Mononuclear; Male; Monitoring, Immunologic; Neuroprotective Agents; Niacinamide; Perioperative Care; Peritonitis; Severity of Illness Index; Succinates; Suppuration; Surgical Procedures, Operative; Treatment Outcome | 2012 |
[Metabolic correction of the lipid-transport system in experimental diffuse purulent peritonitis].
Topics: Animals; Biological Transport; Combined Modality Therapy; Drug Combinations; Drug Monitoring; Flavin Mononucleotide; Infusions, Intravenous; Inosine Diphosphate; Laparotomy; Lipid Metabolism; Male; Models, Animal; Niacinamide; Peritoneal Lavage; Peritonitis; Phosphocreatine; Protective Agents; Rabbits; Research Report; Succinates; Suppuration; Time Factors; Treatment Outcome; Vitamins | 2012 |
[Energy corrective and antioxidative actions of cytoflavin during postischemic period of human dermal fibroblasts in vitro].
Topics: Adenosine Triphosphate; Antioxidants; Blotting, Western; Cell Culture Techniques; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Data Interpretation, Statistical; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum Chaperone BiP; Energy Metabolism; Fibroblasts; Flavin Mononucleotide; Flow Cytometry; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Hydrogen Peroxide; Inosine Diphosphate; Models, Biological; Niacinamide; Oxidative Stress; Oxygen; Reactive Oxygen Species; Reperfusion Injury; Skin; Succinates | 2012 |
[Correction of bioenergetic processes in small intestine during experimental widespread purulent peritonitis].
Topics: Animals; Bacillus; Drug Combinations; Escherichia coli; Flavin Mononucleotide; Injections, Intraperitoneal; Injections, Intravenous; Inosine Diphosphate; Intestine, Small; Male; Mitochondria; Muscle, Smooth; Niacinamide; Oxidative Phosphorylation; Peritonitis; Phosphocreatine; Rabbits; Succinates; Suppuration | 2012 |
[The use of cytoflavin in sports nutrition].
Topics: Adult; Athletic Performance; Dietary Supplements; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Niacinamide; Physical Fitness; Succinates | 2012 |
[Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
Topics: Adult; Brain Injuries; Cognition Disorders; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypoxia, Brain; Inosine Diphosphate; Male; Niacinamide; Psychotropic Drugs; Succinates | 2012 |
[Free radical processes in the pathogenesis of involutional skin changes].
Topics: Adolescent; Adult; Age Factors; Aged; Colorimetry; Drug Combinations; Face; Female; Flavin Mononucleotide; Free Radicals; Humans; Inosine Diphosphate; Laser-Doppler Flowmetry; Lipid Peroxides; Middle Aged; Neck; Niacinamide; Oxygen; Severity of Illness Index; Skin Diseases; Succinates; Treatment Outcome; Vitamin B Complex; Young Adult | 2012 |
[Free-radical oxidation in liver during experimental widespread purulent peritonitis].
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Drug Combinations; Flavin Mononucleotide; Free Radicals; Inosine Diphosphate; Lipid Peroxidation; Liver; Male; Niacinamide; Peritonitis; Phosphocreatine; Rabbits; Succinates | 2012 |
[The preventive treatment of stroke in patients with discirculatory encephalopathy with a depressive syndrome].
Topics: Cerebrovascular Disorders; Depressive Disorder; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypertension; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Psychiatric Status Rating Scales; Stroke; Succinates; Treatment Outcome | 2012 |
[Approaches to the improvement of treatment efficacy in patients with acute severe asaleptin intoxication complicated by acute respiratory insufficiency of mixed genesis].
Topics: Acute Disease; Adult; Antipsychotic Agents; Clozapine; Drug Combinations; Female; Flavin Mononucleotide; Humans; Hypoxia; Inosine Diphosphate; Male; Metabolic Diseases; Middle Aged; Niacinamide; Respiratory Insufficiency; Severity of Illness Index; Succinates; Young Adult | 2012 |
[The diagnostics of adaptive reactions of blood on application the stress-modulating therapy in patients with brain chronic ischemia].
Topics: Adult; Brain Ischemia; Chronic Disease; Delta Sleep-Inducing Peptide; Drug Combinations; Erythrocytes; Flavin Mononucleotide; Glycine; Humans; Inosine Diphosphate; Middle Aged; Niacinamide; Succinates | 2012 |
[Protective effect of cytoflavin and its components in mice with acute alloxan intoxication].
Topics: Acute Disease; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Drug Combinations; Female; Flavin Mononucleotide; Hyperglycemia; Inosine Diphosphate; Male; Mice; Niacinamide; Succinates | 2013 |
[Experimental evaluation of reamberin and cytoflavin effects on the course and outcome of acute burn injury].
Topics: Acute Disease; Animals; Burns; Drug Combinations; Drug Evaluation, Preclinical; Female; Flavin Mononucleotide; Hypoxia; Inosine Diphosphate; Male; Meglumine; Niacinamide; Rats; Succinates | 2013 |
[Pharmacological treatment of hemorheological disorders in children with acute respiratory viral infection].
Topics: Acute Disease; Blood Viscosity; Child; Child, Preschool; Drug Combinations; Erythrocyte Aggregation; Female; Flavin Mononucleotide; Humans; Infant; Inosine Diphosphate; Male; Neurotoxicity Syndromes; Niacinamide; Respiratory Tract Infections; Succinates; Virus Diseases | 2013 |
[Use of metabolic drugs and psychotherapy in dental implantation in elderly patients].
Topics: Aged; Cognitive Behavioral Therapy; Dental Implantation; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Succinates; Tooth Loss; Treatment Outcome | 2013 |
[Cerebral dysfunction after coronary artery bypass graft surgery with cardiopulmonary bypass].
Topics: Aged; Brain Diseases; Cardiopulmonary Bypass; Cognitive Dissonance; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Postoperative Complications; Succinates | 2013 |
[Features of clinical way and treatment of old and senile patients with severe poisoning with carbon monoxide and the products of combustion].
Topics: Adult; Aged; Aged, 80 and over; Carbon Monoxide; Carbon Monoxide Poisoning; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Meglumine; Middle Aged; Niacinamide; Succinates; Treatment Outcome | 2013 |
[Influence of cytoflavin on symptoms of asthenia, emotional disorders and autonomic regulation in patients with organic asthenic disorder].
Topics: Adult; Asthenia; Autonomic Nervous System; Drug Combinations; Emotions; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Succinates; Treatment Outcome | 2014 |
[The structure of psychopathology associated with addictive disorders, against alcohol addiction and the possibility of it's neurometabolic correction in the elderly].
Topics: Aged; Alcohol Abstinence; Alcohol Drinking; Alcoholism; Attitude to Health; Behavior, Addictive; Behavioral Symptoms; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Models, Psychological; Neuroprotective Agents; Neurotic Disorders; Niacinamide; Psychopathology; Succinates; Treatment Outcome | 2013 |
[Features of psychopharmacotherapeutic correction of alcohol dependence in the elderly].
Topics: Age Factors; Aged; Alcohol-Induced Disorders, Nervous System; Alcoholism; Behavioral Symptoms; Drug Combinations; Drug Monitoring; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Prevalence; Russia; Succinates; Treatment Outcome | 2013 |
Age-related features of Cytoflavin effectiveness during experimental myocardial ischemia.
Topics: Adenosine Triphosphate; Age Factors; Animals; Cardiotonic Agents; Drug Combinations; Enzyme Activation; Flavin Mononucleotide; Inosine Diphosphate; Male; Mitochondria; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Niacinamide; Rats; Rats, Wistar; Succinates | 2014 |
[The structure of psychopathology associated with addictive disorders, against alcohol addiction and the possibility of its neurometabolic correction of the elderly].
Topics: Aged; Alcoholism; Antioxidants; Behavioral Symptoms; Brain; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Niacinamide; Psychiatric Status Rating Scales; Psychological Techniques; Psychopathology; Succinates; Treatment Outcome | 2014 |
[The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
Topics: Animals; Animals, Outbred Strains; Antioxidants; Catalase; Drug Combinations; Dyslipidemias; Erythrocytes; Female; Flavin Mononucleotide; Inosine Diphosphate; Lipid Peroxidation; Male; Malondialdehyde; Niacinamide; Protective Agents; Pyridones; Rats; Succinates; Superoxide Dismutase | 2014 |
[The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Topics: Animals; Anxiety; Disease Models, Animal; Drug Combinations; Dyslipidemias; Emotions; Flavin Mononucleotide; Inosine Diphosphate; Male; Niacinamide; Picolines; Rats; Succinates | 2014 |
[Comparative experimental study of the influence of drugs that improve brain metabolism (angiogen, cytoflavin) on neuronal apoptosis and function of cerebral cortex during aging].
Topics: Aging; Animals; Apoptosis; Aspirin; Behavior, Animal; Caspase 3; Caspase 8; Cerebral Cortex; Cognition; Drug Combinations; Flavin Mononucleotide; Gene Expression; Inosine Diphosphate; Mice; Mice, Transgenic; Motor Activity; Motor Neurons; Neuroprotective Agents; Niacinamide; Sensory Receptor Cells; Succinates; Succinic Acid; Tumor Suppressor Protein p53 | 2015 |
[Characteristics of the regulation of neurotrophic mechanisms in ischemic stroke].
Topics: Animals; Astrocytes; Disease Models, Animal; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Male; Nerve Growth Factors; Neurons; Neuroprotective Agents; Niacinamide; Nitric Oxide; Phosphopyruvate Hydratase; Rats; Stroke; Succinates; Vascular Endothelial Growth Factor A | 2015 |
[THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
Topics: Adult; Aged; Diabetic Foot; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Neuroprotective Agents; Niacinamide; Succinates; Syndrome; Treatment Outcome | 2015 |
[PREVENTION AND CORRECTION OF PULMONARY COMPLICATIONS FOR SEVERE ACUTE PANCREATITIS].
Topics: Acute Disease; Acute Lung Injury; Adult; Aged; Antioxidants; Capillary Permeability; Diaphragm; Drug Combinations; Exudates and Transudates; Female; Flavin Mononucleotide; Fluid Therapy; Humans; Inosine Diphosphate; Interleukin-8; Lipid Peroxidation; Lung; Male; Middle Aged; Niacinamide; Pancreas; Pancreatitis; Peritoneum; Pleura; Protective Agents; Succinates; Tumor Necrosis Factor-alpha; Vasodilation | 2015 |
[Therapeutic possibilities of improvement of cognitive functions, psychoemotional condition and a quality of life in post-stroke patients].
Topics: Adult; Aged; Aged, 80 and over; Anxiety; Cognition; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Psychiatric Status Rating Scales; Quality of Life; Stroke; Succinates; Surveys and Questionnaires; Treatment Outcome | 2015 |
[ROLE OF SUBSTRATE ANTIHYPOXANTS IN CORRECTION OF ABNORMALITIES OF MYOELECTRICAL ACTIVITY OF GASTROINTESTINAL TRACT IN VICTIMS WITH SEVERE COMBINED TRAUMA].
Topics: Administration, Intravenous; Adult; Drug Combinations; Electrodiagnosis; Female; Flavin Mononucleotide; Gastrointestinal Motility; Gastrointestinal Tract; Humans; Inosine Diphosphate; Male; Middle Aged; Multiple Trauma; Myoelectric Complex, Migrating; Neuroprotective Agents; Niacinamide; Preoperative Care; Shock, Traumatic; Succinates; Surgical Procedures, Operative; Trauma Severity Indices; Treatment Outcome | 2015 |
[Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease].
Topics: Adult; Aged; Antihypertensive Agents; Anxiety; Autonomic Nervous System Diseases; Cognition Disorders; Depression; Drug Combinations; Drug Therapy, Combination; Female; Flavin Mononucleotide; Humans; Hypertension; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Severity of Illness Index; Succinates; Treatment Outcome | 2016 |
[Behavioral psychotherapy and citoftavin in the treatment of deforming coxarthrosis in elderly patients].
Topics: Aged; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Male; Neuroprotective Agents; Niacinamide; Osteoarthritis, Hip; Pain; Pain Management; Quality of Life; Succinates; Treatment Outcome | 2016 |
[Evaluation of bio-inverse communication and Cytoflavin effects on the dynamics of the clinical and psychophysiological condition of elderly patients with osteochondrosis].
Topics: Aged; Communication; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Niacinamide; Osteochondrosis; Succinates; Treatment Outcome | 2017 |
[TACTICS OF CHOOSING COGNITIVE DYSFUNCTION THERAPY IN THE POSTOPERATIVE PERIOD].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cognition Disorders; Cytidine Diphosphate Choline; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Neuroprotective Agents; Neuropsychological Tests; Niacinamide; Postoperative Complications; Psychometrics; Succinates | 2017 |
SURGICAL PREVENTION AND TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM IN PATIENTS OPERATED ON THYROID GLAND.
Topics: Antioxidants; Drug Combinations; Flavin Mononucleotide; Humans; Hypoparathyroidism; Hypoxia; Inosine Diphosphate; Middle Aged; Niacinamide; Parathyroid Glands; Postoperative Complications; Succinates; Thyroid Diseases | 2018 |
[EFFECT OF CITOFLAVIN ON THE PARAMETERS OF LIPID PEROXIDATION IN BLOOD PLASMA OF RATS UNDER COLD STRESS CONDITIONS.]
Topics: Animals; Cold-Shock Response; Drug Combinations; Flavin Mononucleotide; Hypothermia; Inosine Diphosphate; Lipid Peroxidation; Male; Niacinamide; Rats; Succinates | 2016 |
[MORPHOLOGICAL CHANGES IN RAT MYOCARDIUM EXPOSED TO HEMIC HYPOXIA AND TREATED WITH CYTOFLAVIN.]
Topics: Animals; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin Mononucleotide; Hypoxia; Inosine Diphosphate; Myocardium; Myocytes, Cardiac; Niacinamide; Rats; Sodium Nitrite; Succinates | 2016 |
[STRESS-PROTECTIVE EFFECT OF CYTOFLAVIN ON CHRONIC CEREBRAL ISCHEMIA IN RATS.]
Topics: Animals; Brain Ischemia; Chronic Disease; Drug Combinations; Erythrocytes; Flavin Mononucleotide; Inosine Diphosphate; Leukocyte Count; Male; Niacinamide; Rats; Rats, Wistar; Succinates | 2016 |
[THE EFFECT OF CYTOFLAVIN ON PARAMETERS OF THE LEFT VENTRICULAR SYSTOLIC FUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION.]
Topics: Adult; Aged; Biomarkers; Cardiotonic Agents; Case-Control Studies; Coronary Vessels; Creatine Kinase; Drug Administration Schedule; Drug Combinations; Female; Flavin Mononucleotide; Gene Expression; Heart Ventricles; Humans; Inosine Diphosphate; Male; Middle Aged; Myocardial Infarction; Niacinamide; Stents; Stroke Volume; Succinates; Systole; Treatment Outcome; Troponin I; Ventricular Function, Left | 2017 |
[The intraoperative prophylaxis of local ischemical brain damage in neurosurgical patients with cerebral aneurysm].
Topics: Brain; Brain Injuries; Brain Ischemia; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Intracranial Aneurysm; Intraoperative Care; Neuroprotective Agents; Neurosurgical Procedures; Niacinamide; Prospective Studies; Succinates; Suture Techniques | 2019 |
[Variants of postoperative delirium suppression in elderly patients.]
Topics: Aged; Antioxidants; Delirium; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Niacinamide; Postoperative Complications; Pyridines; Succinates | 2019 |
[Effects of cytoflavin on neuronal apoptotic processes in the murine cerebral cortex on a model of physiologicaland pathological aging].
Topics: Aging; Animals; Apoptosis; Cerebral Cortex; Disease Models, Animal; Drug Combinations; Female; Flavin Mononucleotide; Inosine Diphosphate; Mice; Niacinamide; Succinates | 2019 |
[Substantiation of the drug «Cytoflavin» application and cognitive-behavioral therapy in complex treatment of deforming coxarthrosis in elderly patients.]
Topics: Aged; Cognitive Behavioral Therapy; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Neuroprotective Agents; Niacinamide; Osteoarthritis, Hip; Quality of Life; Succinates | 2019 |
[Possibilities for optimizing the pathogenetic therapy of purulent meningitis in children].
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Combinations; Flavin Mononucleotide; Glycosaminoglycans; Humans; Infant; Inosine Diphosphate; Meningitis; Meningitis, Bacterial; Niacinamide; Succinates | 2019 |
[Cytoflavin in patients with vertigo and dizziness in a distant period of mild traumatic brain injury].
Topics: Adult; Brain Concussion; Dizziness; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Middle Aged; Niacinamide; Succinates; Vertigo; Young Adult | 2020 |
[Cytoflavin effect on locomotor and psychoemotional status in physiological and pathological aging.]
Topics: Aging; Animals; Drug Combinations; Emotions; Flavin Mononucleotide; Inosine Diphosphate; Locomotion; Male; Mice; Niacinamide; Succinates | 2020 |
[Violations of higher mental functions and their correction in patients undergoing video laparoscopic cholecystectomy under conditions of inhalation anesthesia with sevoflurane].
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Cholecystectomy, Laparoscopic; Cognition Disorders; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Neuroprotective Agents; Niacinamide; Sevoflurane; Succinates; Video-Assisted Surgery | 2020 |
[Cytoflavin as a modulator of rehabilitation treatment of patients with ischemic stroke complicated by post-intensive care syndrome].
Topics: Brain Ischemia; Critical Care; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Niacinamide; Stroke; Stroke Rehabilitation; Succinates; Treatment Outcome | 2020 |
Evaluation of the Protective Effect of Ademetionine, Cytoflavin, and Dihydroquercetetine on Blood Enzymes Activity in Rats Treated with High Doses of Sodium Valproate.
Topics: Alkaline Phosphatase; Animals; Anticonvulsants; Drug Combinations; Epilepsy; Erythrocytes; Flavin Mononucleotide; gamma-Glutamyltransferase; Inosine Diphosphate; Liver; Male; Niacinamide; Quercetin; Rats; S-Adenosylmethionine; Succinates; Time Factors; Valproic Acid | 2020 |
[Biofeed back therapy and Cytoflavin in the system of medical support of the training process of elderly hockey players.]
Topics: Aged; Antioxidants; Drug Combinations; Flavin Mononucleotide; Hockey; Humans; Inosine Diphosphate; Niacinamide; Succinates | 2021 |
[Development of an algorithm for the appointment of biofeed-back therapy and Cytoflavin for the treatment of osteochondrosis in elderly patients.]
Topics: Aged; Algorithms; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Niacinamide; Osteochondrosis; Succinates; Treatment Outcome | 2021 |
[The effectiveness of cytoflavin in complex therapy of patients with the coronavirus infection COVID-19].
Topics: COVID-19; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Niacinamide; SARS-CoV-2; Succinates; Treatment Outcome | 2021 |
[Comparison of neurotropic and antioxidant activity of Cytoflavin and etilmetilgydroxypiridine succinat in patients with chronic brain ischemia].
Topics: Antioxidants; Brain Ischemia; Female; Humans; Inosine Diphosphate; Niacinamide | 2022 |
[Evaluation of the effectiveness of the drug Cytoflavin in patients with dyscirculatory encephalopathy who have undergone a new coronavirus infection].
Topics: Aged; Brain Diseases; COVID-19; Female; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide | 2023 |
[The successful use of Cytoflavin in the patient with postaveny syndrome].
Topics: Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Niacinamide; Succinates | 2023 |